Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectives.
Pellesi Lanfranco, Scuteri Damiana, Martelletti Paolo·Expert review of neurotherapeutics
INTRODUCTION: Migraine is among the most disabling neurological disorders worldwide and preventive treatment remains a cornerstone for reducing disease burden. Recent advances in mechanism-based therapies have positioned calcitonin gene-related peptide (CGRP) and its main receptor as central targets for migraine prophy…